位置:首页 > 蛋白库 > ACTNA_DICDI
ACTNA_DICDI
ID   ACTNA_DICDI             Reviewed;         861 AA.
AC   P05095; Q55EP1;
DT   13-AUG-1987, integrated into UniProtKB/Swiss-Prot.
DT   20-MAR-2007, sequence version 2.
DT   03-AUG-2022, entry version 170.
DE   RecName: Full=Alpha-actinin A;
DE   AltName: Full=Actin-binding protein A;
DE   AltName: Full=F-actin cross-linking protein;
GN   Name=abpA; Synonyms=actnA; ORFNames=DDB_G0268632;
OS   Dictyostelium discoideum (Slime mold).
OC   Eukaryota; Amoebozoa; Evosea; Eumycetozoa; Dictyostelia; Dictyosteliales;
OC   Dictyosteliaceae; Dictyostelium.
OX   NCBI_TaxID=44689;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=AX2;
RX   PubMed=3622778; DOI=10.1016/0014-5793(87)80962-6;
RA   Noegel A., Witke W., Schleicher M.;
RT   "Calcium-sensitive non-muscle alpha-actinin contains EF-hand structures and
RT   highly conserved regions.";
RL   FEBS Lett. 221:391-396(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=AX4;
RX   PubMed=15875012; DOI=10.1038/nature03481;
RA   Eichinger L., Pachebat J.A., Gloeckner G., Rajandream M.A., Sucgang R.,
RA   Berriman M., Song J., Olsen R., Szafranski K., Xu Q., Tunggal B.,
RA   Kummerfeld S., Madera M., Konfortov B.A., Rivero F., Bankier A.T.,
RA   Lehmann R., Hamlin N., Davies R., Gaudet P., Fey P., Pilcher K., Chen G.,
RA   Saunders D., Sodergren E.J., Davis P., Kerhornou A., Nie X., Hall N.,
RA   Anjard C., Hemphill L., Bason N., Farbrother P., Desany B., Just E.,
RA   Morio T., Rost R., Churcher C.M., Cooper J., Haydock S., van Driessche N.,
RA   Cronin A., Goodhead I., Muzny D.M., Mourier T., Pain A., Lu M., Harper D.,
RA   Lindsay R., Hauser H., James K.D., Quiles M., Madan Babu M., Saito T.,
RA   Buchrieser C., Wardroper A., Felder M., Thangavelu M., Johnson D.,
RA   Knights A., Loulseged H., Mungall K.L., Oliver K., Price C., Quail M.A.,
RA   Urushihara H., Hernandez J., Rabbinowitsch E., Steffen D., Sanders M.,
RA   Ma J., Kohara Y., Sharp S., Simmonds M.N., Spiegler S., Tivey A.,
RA   Sugano S., White B., Walker D., Woodward J.R., Winckler T., Tanaka Y.,
RA   Shaulsky G., Schleicher M., Weinstock G.M., Rosenthal A., Cox E.C.,
RA   Chisholm R.L., Gibbs R.A., Loomis W.F., Platzer M., Kay R.R.,
RA   Williams J.G., Dear P.H., Noegel A.A., Barrell B.G., Kuspa A.;
RT   "The genome of the social amoeba Dictyostelium discoideum.";
RL   Nature 435:43-57(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 91-504, PROTEIN SEQUENCE OF 126-139;
RP   275-285; 293-309; 313-328; 397-405 AND 481-487, AND DEVELOPMENTAL STAGE.
RC   STRAIN=AX2;
RX   PubMed=3745276; DOI=10.1083/jcb.103.3.969;
RA   Witke W., Schleicher M., Lottspeich F., Noegel A.;
RT   "Studies on the transcription, translation, and structure of alpha-actinin
RT   in Dictyostelium discoideum.";
RL   J. Cell Biol. 103:969-975(1986).
RN   [4]
RP   FUNCTION.
RX   PubMed=6746725; DOI=10.1083/jcb.99.1.119s;
RA   Condeelis J., Vahey M., Carboni J.M., DeMey J., Ogihara S.;
RT   "Properties of the 120,000- and 95,000-dalton actin-binding proteins from
RT   Dictyostelium discoideum and their possible functions in assembling the
RT   cytoplasmic matrix.";
RL   J. Cell Biol. 99:119-126(1984).
RN   [5]
RP   FUNCTION, SUBUNIT, AND DISRUPTION PHENOTYPE.
RX   PubMed=3956480; DOI=10.1002/j.1460-2075.1986.tb04178.x;
RA   Wallraff E., Schleicher M., Modersitzki M., Rieger D., Isenberg G.,
RA   Gerisch G.;
RT   "Selection of Dictyostelium mutants defective in cytoskeletal proteins: use
RT   of an antibody that binds to the ends of alpha-actinin rods.";
RL   EMBO J. 5:61-67(1986).
RN   [6]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=1732064; DOI=10.1016/0092-8674(92)90205-q;
RA   Witke W., Schleicher M., Noegel A.A.;
RT   "Redundancy in the microfilament system: abnormal development of
RT   Dictyostelium cells lacking two F-actin cross-linking proteins.";
RL   Cell 68:53-62(1992).
RN   [7]
RP   FUNCTION, AND MUTAGENESIS OF ASP-742; ASP-744; ASP-746; GLU-753; ASP-778;
RP   ASP-780; SER-786 AND GLU-789.
RX   PubMed=8486739; DOI=10.1083/jcb.121.3.599;
RA   Witke W., Hofmann A., Koeppel B., Schleicher M., Noegel A.A.;
RT   "The Ca(2+)-binding domains in non-muscle type alpha-actinin: biochemical
RT   and genetic analysis.";
RL   J. Cell Biol. 121:599-606(1993).
RN   [8]
RP   SUBCELLULAR LOCATION.
RX   PubMed=7820857; DOI=10.1002/cm.970290105;
RA   Furukawa R., Fechheimer M.;
RT   "Differential localization of alpha-actinin and the 30 kD actin-bundling
RT   protein in the cleavage furrow, phagocytic cup, and contractile vacuole of
RT   Dictyostelium discoideum.";
RL   Cell Motil. Cytoskeleton 29:46-56(1994).
RN   [9]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=8937986; DOI=10.1242/jcs.109.11.2679;
RA   Rivero F., Koeppel B., Peracino B., Bozzaro S., Siegert F., Weijer C.J.,
RA   Schleicher M., Albrecht R., Noegel A.A.;
RT   "The role of the cortical cytoskeleton: F-actin crosslinking proteins
RT   protect against osmotic stress, ensure cell size, cell shape and motility,
RT   and contribute to phagocytosis and development.";
RL   J. Cell Sci. 109:2679-2691(1996).
RN   [10]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=10411959;
RA   Weber I.;
RT   "Computer-assisted morphometry of cell-substratum contacts.";
RL   Croat. Med. J. 40:334-339(1999).
RN   [11]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=10413681; DOI=10.1242/jcs.112.16.2737;
RA   Rivero F., Furukawa R., Fechheimer M., Noegel A.A.;
RT   "Three actin cross-linking proteins, the 34 kDa actin-bundling protein,
RT   alpha-actinin and gelation factor (ABP-120), have both unique and redundant
RT   roles in the growth and development of Dictyostelium.";
RL   J. Cell Sci. 112:2737-2751(1999).
RN   [12]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=10704840; DOI=10.1016/s0925-4773(99)00292-0;
RA   Ponte E., Rivero F., Fechheimer M., Noegel A., Bozzaro S.;
RT   "Severe developmental defects in Dictyostelium null mutants for actin-
RT   binding proteins.";
RL   Mech. Dev. 91:153-161(2000).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 265-502.
RX   PubMed=11226153; DOI=10.1093/emboj/20.1.40;
RA   Kliche W., Fujita-Becker S., Kollmar M., Manstein D.J., Kull F.J.;
RT   "Structure of a genetically engineered molecular motor.";
RL   EMBO J. 20:40-46(2001).
CC   -!- FUNCTION: F-actin cross-linking protein which is thought to anchor
CC       actin to a variety of intracellular structures. This is a bundling
CC       protein. Increases the actin-stimulated ATPase activity of myosin.
CC       Involved in vegetative cell growth, phagocytosis, motility and
CC       development, probably through stabilization of the actin network in the
CC       cortical cytoskeleton. {ECO:0000269|PubMed:10411959,
CC       ECO:0000269|PubMed:10413681, ECO:0000269|PubMed:10704840,
CC       ECO:0000269|PubMed:1732064, ECO:0000269|PubMed:3956480,
CC       ECO:0000269|PubMed:6746725, ECO:0000269|PubMed:8486739,
CC       ECO:0000269|PubMed:8937986}.
CC   -!- SUBUNIT: Homodimer; antiparallel. {ECO:0000269|PubMed:3956480}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:7820857}.
CC       Cytoplasm, cell cortex {ECO:0000269|PubMed:7820857}. Contractile
CC       vacuole {ECO:0000269|PubMed:7820857}. Cytoplasmic vesicle, phagosome
CC       {ECO:0000269|PubMed:7820857}. Note=Expressed diffusely throughout the
CC       cytoplasm. Accumulates in the cell cortex, contractile vesicle and
CC       phagosome.
CC   -!- DEVELOPMENTAL STAGE: Expressed throughout development. Levels increase
CC       during aggregation (1-6 hours) and are then maintained until late
CC       culmination when they start to decrease. {ECO:0000269|PubMed:3745276}.
CC   -!- DISRUPTION PHENOTYPE: Cells show a minor impairment of growth under
CC       conditions of reduced temperature and hyperosmotic stress. Fruiting
CC       body development and spore production on soil plates is strongly
CC       impaired in mutants lacking abpA, but is only mildly affected in
CC       mutants on agar plates. Double mutants lacking both abpA and abpC show
CC       a marked reduction in growth, cell size and resistance to osmotic
CC       shock, and decreased motility and phagocytosis rates. Development is
CC       blocked at the tip stage of aggregation, although expression of
CC       developmentally regulated genes does not appear to be affected. Double
CC       mutants lacking abpA and abpB show a significant reduction in growth
CC       and a slight reduction in motility. Development appears to proceed
CC       normally until culmination when aberrant fruiting bodies are formed.
CC       The phenotypes of the double mutants suggests a partial redundancy in
CC       the microfilament system. {ECO:0000269|PubMed:10411959,
CC       ECO:0000269|PubMed:10413681, ECO:0000269|PubMed:10704840,
CC       ECO:0000269|PubMed:1732064, ECO:0000269|PubMed:3956480,
CC       ECO:0000269|PubMed:8937986}.
CC   -!- SIMILARITY: Belongs to the alpha-actinin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Y00689; CAA68685.1; -; mRNA.
DR   EMBL; AAFI02000004; EAL72905.1; -; Genomic_DNA.
DR   EMBL; X04324; CAA27855.1; -; Genomic_DNA.
DR   PIR; S00103; FADOAA.
DR   RefSeq; XP_646979.1; XM_641887.1.
DR   PDB; 1G8X; X-ray; 2.80 A; A/B=265-502.
DR   PDB; 4PD3; X-ray; 2.84 A; A/B=265-502.
DR   PDB; 5I4E; X-ray; 2.25 A; A=265-489.
DR   PDB; 5JLH; EM; 3.90 A; F/G=265-502.
DR   PDBsum; 1G8X; -.
DR   PDBsum; 4PD3; -.
DR   PDBsum; 5I4E; -.
DR   PDBsum; 5JLH; -.
DR   AlphaFoldDB; P05095; -.
DR   SMR; P05095; -.
DR   STRING; 44689.DDB0191133; -.
DR   PaxDb; P05095; -.
DR   PRIDE; P05095; -.
DR   EnsemblProtists; EAL72905; EAL72905; DDB_G0268632.
DR   GeneID; 8616670; -.
DR   KEGG; ddi:DDB_G0268632; -.
DR   dictyBase; DDB_G0268632; abpA.
DR   eggNOG; KOG0035; Eukaryota.
DR   HOGENOM; CLU_005217_0_2_1; -.
DR   InParanoid; P05095; -.
DR   OMA; IMILVDP; -.
DR   PhylomeDB; P05095; -.
DR   Reactome; R-DDI-114608; Platelet degranulation.
DR   Reactome; R-DDI-6798695; Neutrophil degranulation.
DR   Reactome; R-DDI-6807878; COPI-mediated anterograde transport.
DR   Reactome; R-DDI-9013418; RHOBTB2 GTPase cycle.
DR   Reactome; R-DDI-9013420; RHOU GTPase cycle.
DR   Reactome; R-DDI-9013424; RHOV GTPase cycle.
DR   EvolutionaryTrace; P05095; -.
DR   PRO; PR:P05095; -.
DR   Proteomes; UP000002195; Chromosome 1.
DR   GO; GO:0005884; C:actin filament; IDA:dictyBase.
DR   GO; GO:0005938; C:cell cortex; IDA:dictyBase.
DR   GO; GO:0030054; C:cell junction; IBA:GO_Central.
DR   GO; GO:0031252; C:cell leading edge; IDA:dictyBase.
DR   GO; GO:0042995; C:cell projection; IBA:GO_Central.
DR   GO; GO:0000331; C:contractile vacuole; IEA:UniProtKB-SubCell.
DR   GO; GO:0030864; C:cortical actin cytoskeleton; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IDA:dictyBase.
DR   GO; GO:0031012; C:extracellular matrix; IDA:dictyBase.
DR   GO; GO:0070685; C:macropinocytic cup; IDA:dictyBase.
DR   GO; GO:0045335; C:phagocytic vesicle; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0031143; C:pseudopodium; IDA:dictyBase.
DR   GO; GO:0051015; F:actin filament binding; IDA:dictyBase.
DR   GO; GO:0005509; F:calcium ion binding; IDA:dictyBase.
DR   GO; GO:0030674; F:protein-macromolecule adaptor activity; IDA:dictyBase.
DR   GO; GO:0005200; F:structural constituent of cytoskeleton; IDA:dictyBase.
DR   GO; GO:0051764; P:actin crosslink formation; IDA:UniProtKB.
DR   GO; GO:0030036; P:actin cytoskeleton organization; IBA:GO_Central.
DR   GO; GO:0051017; P:actin filament bundle assembly; IDA:dictyBase.
DR   GO; GO:0048870; P:cell motility; IGI:dictyBase.
DR   GO; GO:0009267; P:cellular response to starvation; IEP:dictyBase.
DR   GO; GO:0006972; P:hyperosmotic response; IGI:dictyBase.
DR   GO; GO:0006909; P:phagocytosis; IGI:dictyBase.
DR   GO; GO:0030587; P:sorocarp development; IGI:dictyBase.
DR   CDD; cd00014; CH; 2.
DR   CDD; cd00051; EFh; 1.
DR   CDD; cd00176; SPEC; 2.
DR   Gene3D; 1.10.418.10; -; 2.
DR   InterPro; IPR001589; Actinin_actin-bd_CS.
DR   InterPro; IPR001715; CH-domain.
DR   InterPro; IPR036872; CH_dom_sf.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR014837; EF-hand_Ca_insen.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR018159; Spectrin/alpha-actinin.
DR   InterPro; IPR002017; Spectrin_repeat.
DR   Pfam; PF00307; CH; 2.
DR   Pfam; PF13499; EF-hand_7; 1.
DR   Pfam; PF08726; EFhand_Ca_insen; 1.
DR   Pfam; PF00435; Spectrin; 3.
DR   SMART; SM00033; CH; 2.
DR   SMART; SM00054; EFh; 2.
DR   SMART; SM00150; SPEC; 4.
DR   SUPFAM; SSF47473; SSF47473; 1.
DR   SUPFAM; SSF47576; SSF47576; 1.
DR   PROSITE; PS00019; ACTININ_1; 1.
DR   PROSITE; PS00020; ACTININ_2; 1.
DR   PROSITE; PS50021; CH; 2.
DR   PROSITE; PS00018; EF_HAND_1; 2.
DR   PROSITE; PS50222; EF_HAND_2; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Actin-binding; Calcium; Cytoplasm; Cytoplasmic vesicle;
KW   Developmental protein; Direct protein sequencing; Metal-binding;
KW   Reference proteome; Repeat; Vacuole.
FT   CHAIN           1..861
FT                   /note="Alpha-actinin A"
FT                   /id="PRO_0000073445"
FT   DOMAIN          22..127
FT                   /note="Calponin-homology (CH) 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00044"
FT   DOMAIN          136..242
FT                   /note="Calponin-homology (CH) 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00044"
FT   REPEAT          240..365
FT                   /note="Spectrin 1"
FT   REPEAT          366..480
FT                   /note="Spectrin 2"
FT   REPEAT          481..601
FT                   /note="Spectrin 3"
FT   REPEAT          602..714
FT                   /note="Spectrin 4"
FT   DOMAIN          729..764
FT                   /note="EF-hand 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   DOMAIN          765..800
FT                   /note="EF-hand 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   REGION          1..239
FT                   /note="Actin-binding"
FT   BINDING         742
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         744
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         746
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         748
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         753
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         778
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         780
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         782
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         784
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         789
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   MUTAGEN         742
FT                   /note="D->A: Abolishes cross-linking activity and reduces
FT                   calcium binding by 55%; when associated with A-744; A-746
FT                   and A-753."
FT                   /evidence="ECO:0000269|PubMed:8486739"
FT   MUTAGEN         744
FT                   /note="D->A: Abolishes cross-linking activity and reduces
FT                   calcium binding by 55%; when associated with A-742; A-746
FT                   and A-753."
FT                   /evidence="ECO:0000269|PubMed:8486739"
FT   MUTAGEN         746
FT                   /note="D->A: Abolishes cross-linking activity and reduces
FT                   calcium binding by 55%; when associated with A-742; A-744
FT                   and A-753."
FT                   /evidence="ECO:0000269|PubMed:8486739"
FT   MUTAGEN         753
FT                   /note="E->A: Abolishes cross-linking activity and reduces
FT                   calcium binding by 55%; when associated with A-742; A-744
FT                   and A-746."
FT                   /evidence="ECO:0000269|PubMed:8486739"
FT   MUTAGEN         778
FT                   /note="D->A: Decreases sensitivity to inhibition by
FT                   calcium; when associated with A-780; A-786 and A-789."
FT                   /evidence="ECO:0000269|PubMed:8486739"
FT   MUTAGEN         780
FT                   /note="D->A: Decreases sensitivity to inhibition by
FT                   calcium; when associated with A-778; A-786 and A-789."
FT                   /evidence="ECO:0000269|PubMed:8486739"
FT   MUTAGEN         786
FT                   /note="S->A: Decreases sensitivity to inhibition by
FT                   calcium; when associated with A-778; A-780 and A-789."
FT                   /evidence="ECO:0000269|PubMed:8486739"
FT   MUTAGEN         789
FT                   /note="E->A: Decreases sensitivity to inhibition by
FT                   calcium; when associated with A-778; A-780 and A-786."
FT                   /evidence="ECO:0000269|PubMed:8486739"
FT   CONFLICT        78
FT                   /note="R -> RR (in Ref. 1; CAA68685)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        359
FT                   /note="T -> P (in Ref. 3; CAA27855)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        500
FT                   /note="I -> T (in Ref. 3; CAA27855)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        675
FT                   /note="A -> R (in Ref. 1; CAA68685)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        696
FT                   /note="I -> L (in Ref. 1; CAA68685)"
FT                   /evidence="ECO:0000305"
FT   HELIX           265..289
FT                   /evidence="ECO:0007829|PDB:5I4E"
FT   HELIX           298..314
FT                   /evidence="ECO:0007829|PDB:5I4E"
FT   HELIX           316..336
FT                   /evidence="ECO:0007829|PDB:5I4E"
FT   TURN            339..341
FT                   /evidence="ECO:0007829|PDB:1G8X"
FT   STRAND          348..350
FT                   /evidence="ECO:0007829|PDB:4PD3"
FT   HELIX           353..404
FT                   /evidence="ECO:0007829|PDB:5I4E"
FT   HELIX           405..409
FT                   /evidence="ECO:0007829|PDB:5I4E"
FT   TURN            415..417
FT                   /evidence="ECO:0007829|PDB:5I4E"
FT   HELIX           418..427
FT                   /evidence="ECO:0007829|PDB:5I4E"
FT   HELIX           428..431
FT                   /evidence="ECO:0007829|PDB:5I4E"
FT   HELIX           432..450
FT                   /evidence="ECO:0007829|PDB:5I4E"
FT   TURN            456..459
FT                   /evidence="ECO:0007829|PDB:5I4E"
FT   HELIX           460..483
FT                   /evidence="ECO:0007829|PDB:5I4E"
FT   HELIX           484..487
FT                   /evidence="ECO:0007829|PDB:1G8X"
FT   TURN            489..494
FT                   /evidence="ECO:0007829|PDB:1G8X"
FT   TURN            496..501
FT                   /evidence="ECO:0007829|PDB:1G8X"
SQ   SEQUENCE   861 AA;  97358 MW;  17F4364B8059EAFA CRC64;
     MSEEPTPVSG NDKQLLNKAW EITQKKTFTA WCNSHLRKLG SSIEQIDTDF TDGIKLAQLL
     EVISNDPVFK VNKTPKLRIH NIQNVGLCLK HIESHGVKLV GIGAEELVDK NLKMTLGMIW
     TIILRFAIQD ISIEELSAKE ALLLWCQRKT EGYDRVKVGN FHTSFQDGLA FCALIHKHRP
     DLINFDSLNK DDKAGNLQLA FDIAEKELDI PKMLDVSDML DVVRPDERSV MTYVAQYYHH
     FSASRKAETA GKQVGKVLDT FMLLEQTKSD YLKRANELVQ WINDKQASLE SRDFGDSIES
     VQSFMNAHKE YKKTEKPPKG QEVSELEAIY NSLQTKLRLI KREPFVAPAG LTPNEIDSTW
     SALEKAEQEH AEALRIELKR QKKIAVLLQK YNRILKKLEN WATTKSVYLG SNETGDSITA
     VQAKLKNLEA FDGECQSLEG QSNSDLLSIL AQLTELNYNG VPELTERKDT FFAQQWTGVK
     SSAETYKNTL LAELERLQKI EDSLVEFAKR AAQLNVWIEA ADDHVFDPIN VDSVQGVQEI
     QEKFDAFLHD QSQQFAELEA LAALTQQLRE LGRSENDYSV ISYDELSAKW NNLLAGIEER
     KVQLANELTT QTNNDVLCQS FSVKANEISD YVRVTLDAIS QNTSSDPQEQ LNNIRAIITA
     HAEKKPELDE LYTIASQLEE AQVVDNKHTQ HSLESIKLKW DKLNTLAKKN EQVVEGEILA
     KQLTGVTAEE LSEFKACFSH FDKDNDNKLN RLEFSSCLKS IGDELTEEQL NQVISKIDTD
     GNGTISFEEF IDYMVSSRKG TDSVESTKAA FKVMAEDKDF ITEAQIRAAI SDSKQIDYLL
     ASMPAVEGGF DYNSFAEKLY Q
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024